U.S. Food and Drug Administration approves first drug made from marijuana
The U.S. Food and Drug Administration on Monday approved the first cannabis-derived drug for sale, which has shown to control seizures in children with life-threatening forms of epilepsy.
Epidiolex, manufactured by GW Pharmaceuticals in the UK, is made from cannabidiol, the non-psychoactive part of the cannabis plant. It was made for children 2 and older who are diagnosed with Dravet syndrome and Lennox-Gastaut syndrome, two serious forms of epilepsy that cause life-long developmental delays.